Healthridge Pharmaceuticals Private Limited

Alpha Ketoanalogues with essential amino acids are specially formulated supplements widely used in patients with chronic kidney disease (CKD) and related conditions. They provide vital amino acids in a modified form that helps reduce the nitrogen burden on the kidneys, while still ensuring adequate nutrition.

Ursodeoxycholic acid (150 mg tablets) is primarily used to dissolve certain types of gallstones and to treat chronic primary biliary cholangitis (PBC), a serious liver disease. It is also used to manage liver and biliary issues in children with cystic fibrosis.   Key Uses

• Dissolving Gallstones: The medication works by reducing the amount of cholesterol produced by the liver and absorbed by the intestines, which decreases the cholesterol saturation of bile. This helps to break down existing gallstones made primarily of cholesterol. This is often an alternative for patients who are not candidates for surgery.
• Treating Primary Biliary Cholangitis (PBC): Ursodeoxycholic acid (UDCA) is the only drug approved by the FDA to treat PBC, an autoimmune disease that damages the small bile ducts in the liver. It helps improve liver function, protects liver cells from toxic bile acids, and can delay the progression of liver damage, especially if started in the early stages.
• Other Conditions: It may also be prescribed to prevent gallstone formation during rapid weight loss programs and to treat liver problems associated with cystic fibrosis in children. It has also been used for intrahepatic cholestasis of pregnancy, an condition that causes intense itching in pregnant women. 

Important Considerations

• Administration: Tablets are typically taken with food, sometimes with a glass of milk or water, to improve absorption. Dosing is determined by your doctor based on your body weight and the specific condition being treated.
• Duration of Treatment: For gallstones, treatment can last several months to two years, continuing for a few months after the stones have completely dissolved. For PBC, the treatment is often lifelong.
• Monitoring: Regular monitoring of liver function (via blood tests) and gallstone status (via ultrasound or X-ray) is necessary during treatment.
• Drug Interactions: Inform your doctor about all other medications you are taking. Certain medications, such as aluminum-based antacids, some cholesterol-lowering agents (like clofibrate), and oral contraceptives containing estrogen, can interfere with the effectiveness of UDCA. 

Torsemide 10 mg and Spironolactone 25 mg is a combination diuretic medication used to treat excess fluid retention (edema) associated with congestive heart failure, liver cirrhosis, and kidney disease. It reduces swelling, manages high blood pressure, and helps maintain potassium balance. Key Uses and Therapeutic Benefits:

• Edema Management: Reduces fluid retention (swelling) in the body, particularly in the legs, abdomen, and lungs, related to congestive heart failure, nephrotic syndrome, or liver cirrhosis.
• High Blood Pressure (Hypertension): Effectively lowers blood pressure by removing excess water and sodium.
• Heart Disease Support: Used to manage edema in heart failure patients to improve symptoms and reduce cardiovascular strain.
• Potassium Balance: The combination of Torsemide (a loop diuretic) and Spironolactone (a potassium-sparing diuretic) helps maintain a healthy balance of potassium, preventing low potassium levels often caused by loop diuretics alone. 

Usage Guidelines:

• Administration: It is typically taken once daily, preferably in the morning with food to prevent frequent nighttime urination.
• Consistency: Take this medicine regularly as prescribed, even if you feel better, as stopping may cause symptoms to return.
• Safety Measures: Avoid alcohol and use with caution if you have kidney disease, high potassium levels, or low blood pressure. 

Common side effects may include dizziness, dehydration, reduced sodium levels, and in men, breast enlargement.